GlassScriptPhysician profile
Kristen E Trom
NPI 1164858700
$10,250.25
in general payments reported to CMS, 2019-2025
46 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $1,187 · 2021: $1,241 · 2022: $1,376 · 2023: $1,639 · 2024: $2,085 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,086.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,528.87 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,361.92 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $833.19 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $765.12 | 2019-2025 | Trelegy Ellipta, Arexvy, Bexsero |
| Amgen INC. | $732.83 | 2019-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $668.12 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $553.50 | 2019-2025 | |
| Astellas Pharma US INC | $285.64 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $264.11 | 2023-2025 | |
| Kowa Pharmaceuticals America, INC. | $243.90 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Abbott Laboratories | $206.44 | 2021-2025 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $162.38 | 2021-2023 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.29 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Exact Sciences Corporation | $137.14 | 2023-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $106.21 | 2021-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Trom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.